Free tool
Heavily traded stocks
We cover 13 companies whose typical session turns over more than $10.00M. The median market value in the group is $263.12B. Across the group, the median move over the past trading day is −1.09%. Price change over the past year runs from −8.0% to +61.5% across the middle 80 percent of the group, with a median of +27.9%.
Other lists in this group
Table
13 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.